Shares of Veritas Pharma Inc.dropped 6.28% today on higher than average trading volume, closing the day at $0.7195 per share. This morning, the company announced that it has completed a prestudy visit of the Fundación de Investigación facilities in Puerto Rico which will be the site where the company’s research arm will be conducting its first human study of CTL-X, a cannabis strain targeting pain management.
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.